• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常发育和癌症中的干细胞。

Stem cells in normal development and cancer.

机构信息

Department of Internal Medicine, Division of Hematology and Oncology, University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.

出版信息

Prog Mol Biol Transl Sci. 2010;95:113-58. doi: 10.1016/B978-0-12-385071-3.00006-X.

DOI:10.1016/B978-0-12-385071-3.00006-X
PMID:21075331
Abstract

In this chapter we provide an overview of stem cells in normal tissues as well as in many different types of cancers. All tissues in the body are derived from organ-specific stem cells that retain the ability to self-renew and differentiate into specific cell types. The cancer stem cell hypothesis suggests that tumors arise from cell populations with dysregulated self-renewal. This may be tissue stem cells or more differentiated cells that acquire self-renewal capabilities. In addition, we outline some useful assays for purification and isolation of cancer stem cells including the dye exclusion side population assay, flow cytometry sorting techniques for identification of putative cancer stem cell markers, tumorspheres assay, aldehyde dehydrogenase activity assay, PKH, and other membrane staining used to label the cancer stem cells, as well as in vivo xenograft transplantation assays. We also examine some of the cell signaling pathways that regulate stem cell self-renewal including the Notch, Hedgehog, HER2/PI3K/Akt/PTEN, and p53 pathways. We also review information demonstrating the involvement of the microenvironment or stem cell niche and its effects on the growth and maintenance of cancer stem cells. Finally, we highlight the therapeutic implications of targeting stem cells by inhibiting these pathways for the treatment and prevention of cancer.

摘要

在本章中,我们提供了对正常组织以及许多不同类型癌症中的干细胞的概述。 体内所有组织均源自具有自我更新能力并能分化为特定细胞类型的器官特异性干细胞。 癌症干细胞假说表明,肿瘤源自自我更新失调的细胞群。 这些细胞可能是组织干细胞或获得自我更新能力的更分化的细胞。 此外,我们概述了一些用于纯化和分离癌症干细胞的有用方法,包括染料排斥性侧群测定法,用于鉴定假定的癌症干细胞标记物的流式细胞术分选技术,肿瘤球体测定法,醛脱氢酶活性测定法,PKH 和其他用于标记癌症干细胞的膜染色,以及体内异种移植移植测定法。 我们还研究了一些调节干细胞自我更新的细胞信号通路,包括 Notch,Hedgehog,HER2 / PI3K / Akt / PTEN 和 p53 通路。 我们还回顾了有关微环境或干细胞生态位及其对癌症干细胞生长和维持的影响的信息。 最后,我们强调了通过抑制这些途径靶向干细胞来治疗和预防癌症的治疗意义。

相似文献

1
Stem cells in normal development and cancer.正常发育和癌症中的干细胞。
Prog Mol Biol Transl Sci. 2010;95:113-58. doi: 10.1016/B978-0-12-385071-3.00006-X.
2
Approaches for targeting self-renewal pathways in cancer stem cells: implications for hematological treatments.靶向癌症干细胞自我更新途径的方法:对血液学治疗的启示。
Expert Opin Drug Discov. 2017 May;12(5):465-474. doi: 10.1080/17460441.2017.1303477. Epub 2017 Mar 14.
3
Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.芳烃受体/细胞色素P450 1A1途径通过抑制PTEN以及激活β-连环蛋白和Akt介导乳腺癌干细胞的扩增。
Mol Cancer. 2017 Jan 19;16(1):14. doi: 10.1186/s12943-016-0570-y.
4
Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.简明综述:CD44在癌症干细胞中的新兴作用:一种有前景的生物标志物和治疗靶点
Stem Cells Transl Med. 2015 Sep;4(9):1033-43. doi: 10.5966/sctm.2015-0048. Epub 2015 Jul 1.
5
Modeling of Cancer Stem Cell State Transitions Predicts Therapeutic Response.癌症干细胞状态转变的建模可预测治疗反应。
PLoS One. 2015 Sep 23;10(9):e0135797. doi: 10.1371/journal.pone.0135797. eCollection 2015.
6
Cancer stem cells: problems for therapy?肿瘤干细胞:治疗的难题?
J Pathol. 2011 Jan;223(2):147-61. doi: 10.1002/path.2793. Epub 2010 Oct 25.
7
Lung cancer stem cells and implications for future therapeutics.肺癌干细胞及其对未来治疗的意义。
Cell Biochem Biophys. 2014 Jul;69(3):389-98. doi: 10.1007/s12013-014-9844-4.
8
The commonality of plasticity underlying multipotent tumor cells and embryonic stem cells.多能肿瘤细胞和胚胎干细胞可塑性的共性。
J Cell Biochem. 2007 Jul 1;101(4):908-17. doi: 10.1002/jcb.21227.
9
Formation and regulation of the cancer stem cell niche.癌症干细胞生态位的形成与调控。
Cancer Sci. 2012 Jul;103(7):1177-81. doi: 10.1111/j.1349-7006.2012.02270.x. Epub 2012 Apr 11.
10
Human non-small cell lung cancer expresses putative cancer stem cell markers and exhibits the transcriptomic profile of multipotent cells.人类非小细胞肺癌表达假定的癌症干细胞标志物,并表现出多能细胞的转录组特征。
BMC Cancer. 2015 Feb 25;15:84. doi: 10.1186/s12885-015-1086-3.

引用本文的文献

1
Defeating lethal cancer: Interrupting the ecologic and evolutionary basis of death from malignancy.战胜致命癌症:阻断恶性肿瘤致死的生态学和进化基础。
CA Cancer J Clin. 2025 May-Jun;75(3):183-202. doi: 10.3322/caac.70000. Epub 2025 Mar 9.
2
TC2N maintains stem cell-like characteristics to accelerate lung carcinogenesis by blockade of dual specificity protein phosphatase 3.TC2N通过阻断双特异性蛋白磷酸酶3来维持干细胞样特征,从而加速肺癌发生。
Cell Biosci. 2025 Jan 23;15(1):8. doi: 10.1186/s13578-025-01348-3.
3
Tumor microenvironment interactions with cancer stem cells in pancreatic ductal adenocarcinoma.
肿瘤微环境与胰腺导管腺癌中癌症干细胞的相互作用。
Adv Cancer Res. 2023;159:343-372. doi: 10.1016/bs.acr.2023.02.007. Epub 2023 Apr 27.
4
Advances in Pancreatic Ductal Adenocarcinoma Treatment.胰腺导管腺癌治疗进展
Cancers (Basel). 2021 Nov 3;13(21):5510. doi: 10.3390/cancers13215510.
5
Twelve unanswered questions in cancer inspired by the life and work of Leland Chung: "if this is true, what does it imply"?受利兰·钟的生平与工作启发的癌症领域的十二个未解答问题:“如果这是真的,这意味着什么?”
Am J Clin Exp Urol. 2021 Aug 25;9(4):254-260. eCollection 2021.
6
Identification and Characterization of Cancer Stem-Like Cells in ALK-Positive Anaplastic Large Cell Lymphoma Using the SORE6 Reporter.利用 SORE6 报告基因鉴定和表征间变性大细胞淋巴瘤中 ALK 阳性的肿瘤干细胞样细胞。
Curr Issues Mol Biol. 2021 Jul 2;43(2):543-557. doi: 10.3390/cimb43020041.
7
Cancer recurrence and lethality are enabled by enhanced survival and reversible cell cycle arrest of polyaneuploid cells.癌症的复发和致死率是由多倍体细胞的生存能力增强和可逆的细胞周期停滞所导致的。
Proc Natl Acad Sci U S A. 2021 Feb 16;118(7). doi: 10.1073/pnas.2020838118.
8
Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape.小分子免疫调节:肿瘤微环境与克服免疫逃逸。
J Immunother Cancer. 2019 Aug 22;7(1):224. doi: 10.1186/s40425-019-0667-0.
9
Tackling tumor heterogeneity and phenotypic plasticity in cancer precision medicine: our experience and a literature review.解决癌症精准医学中的肿瘤异质性和表型可塑性:我们的经验和文献综述。
Cancer Metastasis Rev. 2018 Dec;37(4):655-663. doi: 10.1007/s10555-018-9767-4.
10
Targeting Notch1 and IKKα Enhanced NF-κB Activation in CD133 Skin Cancer Stem Cells.靶向 Notch1 和 IKKα 增强 CD133 皮肤癌干细胞中的 NF-κB 激活。
Mol Cancer Ther. 2018 Sep;17(9):2034-2048. doi: 10.1158/1535-7163.MCT-17-0421. Epub 2018 Jun 29.